|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 103, Issue 3 765-771, Copyright © 1992 by Company of Biologists
JOURNAL ARTICLES |
EJ Mackie and RP Tucker
Rheumatology Research Unit, Addenbrooke's Hospital, Cambridge, UK.
The extracellular matrix glycoprotein, tenascin, is associated in vivo with mesenchyme undergoing osteogenesis and chondrogenesis, but is absent from mature bone and cartilage matrix. The expression of tenascin by osteoblastic cells in vitro has been investigated by immunoblotting and immunocytochemistry. Tenascin was secreted into the medium and deposited in the matrix by human and rat osteoblast-like cell lines, as well as by primary osteoblast-enriched cultures from chick embryo calvarial bones. In primary osteoblast-enriched cultures, extracellular tenascin was found only in cell aggregates expressing the osteoblast marker alkaline phosphatase. Chicken osteoblast cultures synthesized almost exclusively the largest tenascin subunit, whereas fibroblast cultures from periostea of chicken calvariae synthesized approximately equal amounts of all three subunits. In situ hybridization studies of developing chicken bones, using a cDNA probe that hybridizes to all chicken tenascin splice variants, showed specific labelling of both osteogenic and chondrogenic regions of developing endochondral bones. In contrast, a cDNA probe specific for the large tenascin splice variant showed specific hybridization in osteogenic but not chondrogenic regions. Within osteogenic regions, tenascin mRNA was expressed by osteoblasts. A comparison of in situ hybridization and immunohistochemical studies demonstrated that tenascin mRNA and protein were codistributed in osteogenic regions of endochondral and membrane bones, whereas protein was retained in regions of differentiating cartilage where mRNA was no longer detectable. The results presented here demonstrate that tenascin is synthesized by osteoblasts. Moreover, within developing bones, there are at least three different cell type-specific patterns of expression of tenascin splice variants.
This article has been cited by other articles:
![]() |
T. D. Schreiber, C. Steinl, M. Essl, H. Abele, K. Geiger, C. A. Muller, W. K. Aicher, and G. Klein The integrin {alpha}9{beta}1 on hematopoietic stem and progenitor cells: involvement in cell adhesion, proliferation and differentiation Haematologica, November 1, 2009; 94(11): 1493 - 1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Saito, H. Imazeki, S. Miura, T. Yoshimura, H. Okutsu, Y. Harada, T. Ohwaki, O. Nagao, S. Kamiya, R. Hayashi, et al. A Peptide Derived from Tenascin-C Induces 1 Integrin Activation through Syndecan-4 J. Biol. Chem., November 30, 2007; 282(48): 34929 - 34937. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Tso, P. Shintaku, J. Chen, Q. Liu, J. Liu, Z. Chen, K. Yoshimoto, P. S. Mischel, T. F. Cloughesy, L. M. Liau, et al. Primary Glioblastomas Express Mesenchymal Stem-Like Properties Mol. Cancer Res., September 1, 2006; 4(9): 607 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsunoda, H. Inada, I. Kalembeyi, K. Imanaka-Yoshida, M. Sakakibara, R. Okada, K. Katsuta, T. Sakakura, Y. Majima, and T. Yoshida Involvement of Large Tenascin-C Splice Variants in Breast Cancer Progression Am. J. Pathol., June 1, 2003; 162(6): 1857 - 1867. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Puente Navazo, D. Valmori, and C. Ruegg The Alternatively Spliced Domain TnFnIII A1A2 of the Extracellular Matrix Protein Tenascin-C Suppresses Activation-Induced T Lymphocyte Proliferation and Cytokine Production J. Immunol., December 1, 2001; 167(11): 6431 - 6440. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mackie and R. Tucker The tenascin-C knockout revisited J. Cell Sci., January 11, 1999; 112(22): 3847 - 3853. [Abstract] [PDF] |
||||
![]() |
S. Denda, L. F. Reichardt, and U. Müller Identification of Osteopontin as a Novel Ligand for the Integrin alpha 8beta 1 and Potential Roles for This Integrin-Ligand Interaction in Kidney Morphogenesis Mol. Biol. Cell, June 1, 1998; 9(6): 1425 - 1435. [Abstract] [Full Text] |
||||
![]() |
D. Fischer, R. P. Tucker, R. Chiquet-Ehrismann, and J. C. Adams Cell-Adhesive Responses to Tenascin-C Splice Variants Involve Formation of Fascin Microspikes Mol. Biol. Cell, October 1, 1997; 8(10): 2055 - 2075. [Abstract] [Full Text] |
||||
![]() |
A. Moursi, C. Damsky, J Lull, D Zimmerman, S. Doty, S Aota, and R. Globus Fibronectin regulates calvarial osteoblast differentiation J. Cell Sci., January 6, 1996; 109(6): 1369 - 1380. [Abstract] [PDF] |
||||
![]() |
E. Mackie and S Ramsey Modulation of osteoblast behaviour by tenascin J. Cell Sci., January 6, 1996; 109(6): 1597 - 1604. [Abstract] [PDF] |
||||
![]() |
S. Redick and J. Schwarzbauer Rapid intracellular assembly of tenascin hexabrachions suggests a novel cotranslational process J. Cell Sci., January 4, 1995; 108(4): 1761 - 1769. [Abstract] [PDF] |
||||